The abstract is read at the publisher; the summary is JClub's.
Double-negative T-cells (CD3⁺CD4⁻CD8⁻) in a murine glioma model persist after CD4/CD8 depletion and are linked to significantly prolonged survival.
- Why it matters: Glioblastoma’s immunosuppressive microenvironment limits immunotherapy, and the effects of conventional T-cell depletion on remaining T-cell subsets are unclear.
- What they did: In mice, DNT enrichment was profiled by transcriptional and single-cell analyses to assess inflammatory programs and glioma myeloid remodeling; human donor DNTs were tested for effects on glioma stem cells and macrophages, including LAIR1.
- The result: DNTs suppress glioma stem cell viability, enhance macrophage phagocytic activity, reduce LAIR1, and after intracranial delivery significantly prolong survival versus PanT cells in an orthotopic glioblastoma xenograft model.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.